Cizzle Biotechnology MOU to take diagnostic capabilities into the therapeutic arena (Interview)

Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Allan Syms joins DirectorsTalk to discuss the signing of an MOU with St George Street Capital. Allan explains what a companion diagnostic is, what St George Street Capital do, what the proposed commercial agreement will cover and what Cizzle Biotech is looking to achieve over the coming months.

Cizzle Biotechnology MOU to take diagnostic capabilities into the therapeutic arena from DirectorsTalk on Vimeo.